Search Results
Department of Pathology and Molecular Medicine, Queen’s University, Kingston, Ontario, Canada
Search for other papers by Lois M Mulligan in
Google Scholar
PubMed
improve outcomes. The rearranged during transfection (RET) proto-oncogene represents a paradigm for the power of molecular medicine to drive changes in diagnosis and patient management that alter disease outcomes and patient quality of life. Originally
Search for other papers by Barbora Bulanova Pekova in
Google Scholar
PubMed
Search for other papers by Vlasta Sykorova in
Google Scholar
PubMed
Search for other papers by Karolina Mastnikova in
Google Scholar
PubMed
Search for other papers by Eliska Vaclavikova in
Google Scholar
PubMed
Search for other papers by Jitka Moravcova in
Google Scholar
PubMed
Search for other papers by Petr Vlcek in
Google Scholar
PubMed
Search for other papers by Lucie Lancova in
Google Scholar
PubMed
Search for other papers by Petr Lastuvka in
Google Scholar
PubMed
Search for other papers by Rami Katra in
Google Scholar
PubMed
Search for other papers by Petr Bavor in
Google Scholar
PubMed
Search for other papers by Daniela Kodetova in
Google Scholar
PubMed
Search for other papers by Martin Chovanec in
Google Scholar
PubMed
Search for other papers by Jana Drozenova in
Google Scholar
PubMed
Search for other papers by Radoslav Matej in
Google Scholar
PubMed
Search for other papers by Jaromir Astl in
Google Scholar
PubMed
Search for other papers by Jiri Hlozek in
Google Scholar
PubMed
Search for other papers by Petr Hrabal in
Google Scholar
PubMed
Search for other papers by Josef Vcelak in
Google Scholar
PubMed
Search for other papers by Bela Bendlova in
Google Scholar
PubMed
genetic alterations found in thyroid cancer includes different types of mutations: somatic point mutations, indels, copy number alterations, and fusion genes ( Nikiforov 2011 ). Among the fusion genes, the most common and best known are RET (rearranged
Search for other papers by Maria Domenica Castellone in
Google Scholar
PubMed
Dipartimento di Medicina Molecolare e Biotecnologie Mediche, University of Naples ‘Federico II’, Naples, Italy
Search for other papers by Rosa Marina Melillo in
Google Scholar
PubMed
be associated with pheochromocytoma (PC) and parathyroid adenoma/carcinoma in MEN2A or with PC, mucosal neuromas and marphanoid habitus in MEN2B. Activating mutations in the REarranged during Transfection ( RET ) proto-oncogene are responsible for the
Search for other papers by Huy Gia Vuong in
Google Scholar
PubMed
Search for other papers by Toru Odate in
Google Scholar
PubMed
Search for other papers by Hanh T T Ngo in
Google Scholar
PubMed
Search for other papers by Thong Quang Pham in
Google Scholar
PubMed
Search for other papers by Thao T K Tran in
Google Scholar
PubMed
Search for other papers by Kunio Mochizuki in
Google Scholar
PubMed
Search for other papers by Tadao Nakazawa in
Google Scholar
PubMed
Search for other papers by Ryohei Katoh in
Google Scholar
PubMed
Search for other papers by Tetsuo Kondo in
Google Scholar
PubMed
. 2006 ). The RET oncogene was first described in 1985 by Takahashi et al . (1985) . Since then, over 100 genetic alterations involving RET have been found in patients with sporadic and hereditary MTCs. RET mutation occurs in virtually all cases
Search for other papers by Jie Cai in
Google Scholar
PubMed
Search for other papers by Lin Li in
Google Scholar
PubMed
Search for other papers by Lei Ye in
Google Scholar
PubMed
Search for other papers by Xiaohua Jiang in
Google Scholar
PubMed
Search for other papers by Liyun Shen in
Google Scholar
PubMed
Search for other papers by Zhibo Gao in
Google Scholar
PubMed
Search for other papers by Weiyuan Fang in
Google Scholar
PubMed
Search for other papers by Fengjiao Huang in
Google Scholar
PubMed
Search for other papers by Tingwei Su in
Google Scholar
PubMed
Search for other papers by Yulin Zhou in
Google Scholar
PubMed
Search for other papers by Weiqing Wang in
Google Scholar
PubMed
School of Medicine, BGI-Shenzhen, Laboratory for Endocrine and Metabolic Diseases of Institute of Health Science, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University, #197 Ruijin 2nd Road, Shanghai 200025 People's Republic of China
Search for other papers by Guang Ning in
Google Scholar
PubMed
endocrine neoplasms has been observed between and within families. In the early 1990s, direct DNA analysis found mutations in the rearranged during transfection ( RET ) proto-oncogene as the genetic cause of MEN2A ( Mulligan et al . 1993 , Asai et al
Search for other papers by Raffaele Ciampi in
Google Scholar
PubMed
Search for other papers by Thomas J Giordano in
Google Scholar
PubMed
Search for other papers by Kathryn Wikenheiser-Brokamp in
Google Scholar
PubMed
Search for other papers by Ronald J Koenig in
Google Scholar
PubMed
Search for other papers by Yuri E Nikiforov in
Google Scholar
PubMed
Introduction Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer and accounts for ~80% of all thyroid malignancies ( Hundahl et al. 2000 ). Genetic alterations along the RET/RAS/BRAF/ MAPK signaling
Search for other papers by Teresa Ramone in
Google Scholar
PubMed
Search for other papers by Cristina Romei in
Google Scholar
PubMed
Search for other papers by Raffaele Ciampi in
Google Scholar
PubMed
Search for other papers by Roberta Casalini in
Google Scholar
PubMed
Search for other papers by Angelo Valetto in
Google Scholar
PubMed
Search for other papers by Veronica Bertini in
Google Scholar
PubMed
Search for other papers by Francesco Raimondi in
Google Scholar
PubMed
Search for other papers by Anthony Onoja in
Google Scholar
PubMed
Search for other papers by Alessandro Prete in
Google Scholar
PubMed
Search for other papers by Antonio Matrone in
Google Scholar
PubMed
Search for other papers by Carla Gambale in
Google Scholar
PubMed
Search for other papers by Paolo Piaggi in
Google Scholar
PubMed
Search for other papers by Liborio Torregrossa in
Google Scholar
PubMed
Search for other papers by Clara Ugolini in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
the same hospital. For the purpose of this study, we selected 40 MTC cases whose mutation profile was previously identified: 23 cases were positive and 17 negative for RET somatic mutation. The present study was approved by the Institutional Review
Department of Pathology & Molecular Medicine, Queen’s University, Kingston, Ontario, Canada
Search for other papers by Eric Y Lian in
Google Scholar
PubMed
Department of Pathology & Molecular Medicine, Queen’s University, Kingston, Ontario, Canada
Search for other papers by Sarah M Maritan in
Google Scholar
PubMed
Department of Pathology & Molecular Medicine, Queen’s University, Kingston, Ontario, Canada
Search for other papers by Jessica G Cockburn in
Google Scholar
PubMed
Search for other papers by Katayoon Kasaian in
Google Scholar
PubMed
Department of Pathology & Molecular Medicine, Queen’s University, Kingston, Ontario, Canada
Search for other papers by Mathieu J F Crupi in
Google Scholar
PubMed
Search for other papers by David Hurlbut in
Google Scholar
PubMed
Department of Medical Genetics, University of British Columbia, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada
Search for other papers by Steven J M Jones in
Google Scholar
PubMed
Search for other papers by Sam M Wiseman in
Google Scholar
PubMed
Department of Pathology & Molecular Medicine, Queen’s University, Kingston, Ontario, Canada
Search for other papers by Lois M Mulligan in
Google Scholar
PubMed
Introduction The RET receptor tyrosine kinase is required for the development of multiple human tissues ( Mulligan 2014 ). Under normal conditions, RET is activated by binding a glial cell line-derived neurotrophic factor (GDNF) family ligand
Search for other papers by Valtter B Virtanen in
Google Scholar
PubMed
Section of Pediatric Surgery, Finnish Cancer Registry, Tampere School of Health Sciences, Helsinki Medical Imaging Center, Department of Pathology, Section of Pediatrics, Program of Molecular Neurology, The Estonian Genome Center, Hospital for Children and Adolescents, University of Helsinki, Stenbäckinkatu 11, PL 281, FI-00029 HUS Helsinki, Finland
Search for other papers by Eero Pukkala in
Google Scholar
PubMed
Search for other papers by Reetta Kivisaari in
Google Scholar
PubMed
Search for other papers by Perttu P Salo in
Google Scholar
PubMed
Search for other papers by Antti Koivusalo in
Google Scholar
PubMed
Search for other papers by Johanna Arola in
Google Scholar
PubMed
Section of Pediatric Surgery, Finnish Cancer Registry, Tampere School of Health Sciences, Helsinki Medical Imaging Center, Department of Pathology, Section of Pediatrics, Program of Molecular Neurology, The Estonian Genome Center, Hospital for Children and Adolescents, University of Helsinki, Stenbäckinkatu 11, PL 281, FI-00029 HUS Helsinki, Finland
Search for other papers by Päivi J Miettinen in
Google Scholar
PubMed
Search for other papers by Risto J Rintala in
Google Scholar
PubMed
Section of Pediatric Surgery, Finnish Cancer Registry, Tampere School of Health Sciences, Helsinki Medical Imaging Center, Department of Pathology, Section of Pediatrics, Program of Molecular Neurology, The Estonian Genome Center, Hospital for Children and Adolescents, University of Helsinki, Stenbäckinkatu 11, PL 281, FI-00029 HUS Helsinki, Finland
Search for other papers by Markus Perola in
Google Scholar
PubMed
Search for other papers by Mikko P Pakarinen in
Google Scholar
PubMed
neurocristopathies in HD, including familial medullary thyroid carcinoma (MTC), multiple endocrine neoplasia (MEN) syndromes, and neuroblastoma ( Le Douarin & Kalcheim 1999 ). Currently, at least ten genes are known to be involved in pathogenesis of HD. The RET
Search for other papers by J Di Cristofaro in
Google Scholar
PubMed
Search for other papers by V Vasko in
Google Scholar
PubMed
Search for other papers by V Savchenko in
Google Scholar
PubMed
Search for other papers by S Cherenko in
Google Scholar
PubMed
Search for other papers by A Larin in
Google Scholar
PubMed
Search for other papers by M D Ringel in
Google Scholar
PubMed
Search for other papers by M Saji in
Google Scholar
PubMed
Search for other papers by M Marcy in
Google Scholar
PubMed
Search for other papers by J F Henry in
Google Scholar
PubMed
Search for other papers by P Carayon in
Google Scholar
PubMed
Search for other papers by C De Micco in
Google Scholar
PubMed
found among liquidators exposed during recovery work from April to July 1986, when the risk of internal irradiation of the thyroid with incorporated 131 I was greatest. Occurrence of ret oncogene rearrangements involving several different